台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    60.0
  • 漲跌
    ▲0.2
  • 漲幅
    +0.33%
  • 成交量
    11
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智基 (6294)籌碼相關-玉山 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

玉山 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1700.00159.0058.80-191-1.09%
2025/01/15159.0000.0059.001911.09%
2025/01/14159.1000.0059.001911.09%
2025/01/13159.10159.6059.400910.00%
2025/01/10259.8000.0059.602912.20%
2024/12/16162.6000.0062.101901.10%
2024/12/1300.00163.8063.10-189-1.12%
2024/12/12064.0000.0063.800890.02%
2024/12/06465.0000.0065.904944.22%
2024/11/2900.000.463.9064.90-0.498-0.42%
2024/11/280.163.4700.0063.700.1980.12%
2024/11/270.264.9300.0064.700.2990.15%
2024/11/200.267.10266.1064.40-1.991-2.03%
2024/11/1500.000.171.8072.60-0.1101-0.10%
2024/11/142.470.81872.1769.70-5.6102-5.47%
2024/11/13677.9700.0077.406976.16%
2024/11/12186.0000.0086.001901.11%
2024/10/28196.5000.0096.4011350.74%
2024/10/1600.00297.0096.90-2137-1.45%
2024/10/074.196.9800.0096.804.11382.92%
2024/10/0400.00197.0097.00-1138-0.72%
2024/09/30198.0000.0097.3011380.72%
2024/09/270.197.6200.0097.700.11380.07%
2024/09/16396.8000.0096.8031392.15%
2024/09/13097.1000.0096.8001400.01%
2024/09/12196.5100.0096.8011400.72%
2024/09/10297.30296.5096.5001390.00%
2024/09/0900.000.598.5098.10-0.5137-0.38%
2024/09/06199.6000.0099.5011370.73%
2024/09/050100.0000.0099.7001400.01%
2024/09/0300.000100.50100.500139-0.02%
2024/08/293100.5000.00101.0031382.16%
2024/08/281100.5000.00100.5011380.72%
2024/08/271101.0000.00101.0011370.73%
2024/08/210103.0000.00102.0001350.01%
2024/08/1900.003106.66106.00-3130-2.31%
2024/08/152105.0000.00102.5021141.74%
2024/08/132103.2500.00101.5021091.83%
2024/08/092.599.981100.50100.501.5931.61%
2024/08/080103.5000.00105.000950.01%
2024/08/051.198.5900.0098.801.1891.24%
2024/07/220100.5000.00101.000900.01%
2024/07/181101.5000.00101.501901.10%
2024/07/0300.001101.00101.00-1131-0.76%
2024/06/261101.0000.00100.5011370.73%
2024/06/241100.501100.50100.5001390.00%
2024/06/211100.5000.00100.5011400.72%
2024/06/190101.0000.00101.0001430.01%
2024/06/110103.0000.00101.5001560.01%
2024/06/030103.0000.00102.5001590.02%
2024/05/310103.0000.00102.5001590.02%
2024/05/300103.500103.00102.5001590.00%
2024/05/270.1103.5500.00102.500.11580.08%
2024/05/241102.001102.00103.0001570.00%
2024/05/230103.0000.00102.5001570.01%
2024/05/220.1104.0000.00103.000.11570.03%
2024/05/200.5104.5000.00103.500.51540.32%
2024/05/171106.5000.00105.5011520.66%
2024/05/141101.51297.20102.00-1144-0.68%
2024/05/131107.001.2107.00107.00-0.2127-0.14%
2024/05/091118.5000.00118.5011190.83%
2024/05/0700.001119.50119.50-1119-0.84%
2024/05/061118.000119.00119.0011180.84%
2024/04/300.1118.0000.00118.000.11160.09%
2024/04/291118.0000.00117.5011160.86%
2024/04/2400.000.1117.50118.00-0.1115-0.08%
2024/04/1600.000.2114.00114.00-0.2111-0.21%
2024/04/150.1116.500117.00117.000.11070.09%
2024/04/1200.000118.00118.0001040.00%
2024/04/110.1119.4000.00119.500.11010.09%
2024/04/101126.492.7127.25127.00-1.695-1.71%
2024/04/0900.002123.50124.00-277-2.59%
2024/04/080124.0000.00123.500730.03%
2024/04/030123.0000.00123.500710.04%
2024/04/020123.0000.00123.500700.00%
2024/04/011123.0000.00123.001691.44%
2024/03/2900.001122.00122.00-168-1.47%
2024/03/2800.002122.00122.50-267-2.98%
2024/03/272121.5000.00122.002663.02%
2024/03/260123.0000.00123.000630.00%
2024/03/2500.005123.40124.00-562-7.98%
2024/03/220123.0000.00122.500600.03%
2024/03/211122.014.5121.67121.50-3.558-5.89%
2024/03/202.1122.0300.00121.502.1563.64%
2024/03/192.1122.0300.00123.002.1553.83%
2024/03/181123.992122.75124.00-151-1.93%
2024/03/1500.006121.00121.50-647-12.76%
2024/03/142119.002119.00119.000430.00%
2024/03/120.1117.5000.00117.000.1380.13%
2024/03/0800.000.1114.00113.50-0.134-0.34%
2024/03/0500.001113.50113.50-133-2.96%
2024/02/291112.5000.00112.501323.09%
2024/02/262112.0000.00112.002326.17%
2024/02/160111.5000.00111.500310.04%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音